2012 Midyear Clinical Meeting
Click here to go to the previous page
Soothing the Savage Beast: Vignettes in Complicated Pain Management
Track:
Education Sessions (CE)
Program Code: 281-L01
Date: Tuesday, December 4, 2012
Time: 2:00 PM to 4:00 PM EST
Location:
Mandalay Bay F, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Ernest Dole,
PharmD, BCPS, Clinical Pharmacist,
Pain Consultation & Treatment Clinic, University of New Mexico Hospitals
|
Dr. Dole is Clinical Staff Pharmacist III at University of New Mexico Hospitals (UNMH), Department of Clinical Pharmacy and Clinical Associate Professor at University of New Mexico Health Sciences College of Pharmacy. Dr. Dole manages ambulatory care patients with chronic noncancer pain. He received his B.S. in Pharmacy from Colorado, with honors, and his Doctor of Pharmacy degree from Tennessee. He completed a clinical pharmacy practice residency at the Memphis VAMC. Dr. Dole was the ninth Pharmacist Clinician in New Mexico in 1996, was recognized as an ASHP fellow in 1997, passed the Board of Pharmaceutical Specialties Pharmacotherapy exam in 1997, and Certified Diabetes Educator exam in 2000. Dr. Dole has twice been nominated for the NMSHP Pharmacist of the Year. He has been the Chair of American Society of Health-System Pharmacists Section of Home, Ambulatory and Chronic Care Practitioners and has served as a member on ASHP Councils and Task Forces. He has been president of the New Mexico Society of Health-System Pharmacists. Dr. Dole received the Volunteer Faculty of the Year Award and Preceptor of the Year Award from University of New Mexico Health Sciences College of Pharmacy in 2009. Current research is obtaining billing privileges for pharmacists, effect of high opiate doses on testosterone levels and the effect of opiates on sleep apnea.
|
|
Chris Herndon, PharmD, BCPS, CPE, FASHP is an Associate Professor of Pharmacy at Southern Illinois University Edwardsville and a Clinical Assistant Professor of Medicine with the St. Louis University School of Medicine. Currently Dr. Herndon manages a chronic pain service in Belleville, Illinois within a family medicine residency program jointly offered by St. Louis University and the United States Air Force. Prior to joining SIUE, Dr. Herndon served as a Science and Research Liaison with Johnson and Johnson.
Dr. Herndons research interests focus on health professional education in the areas of pain and palliative care and risk mitigation strategies in the use of opioid analgesics. He serves on numerous editorial advisory boards, is the Immediate Past- Chair for the American Society of Health-System Pharmacists Section Advisory Group on Pain and Palliative Care, and has previously served as the ASHP Network Facilitator, Pain. Dr. Herndon is the recipient of a 2009 Pain Initiative Champion Award and was the founding President of the Missouri Pain Initiative. Most recently, Dr. Herndon was in the inaugural class to receive the Certified Pain Educator credential from the American Society of Pain Educators.
|
Michele Matthews,
PharmD, CPE, Associate Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences
|
Michele Matthews, PharmD, CPE earned her degree from the Massachusetts College of Pharmacy and Health Sciences in 2002 and completed a PGY-1 pharmacy practice residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. She is an Associate Professor of Pharmacy Practice at the Massachusetts College of Pharmacy and Health Sciences and is currently a Clinical Pharmacy Specialist in Pain Management at Brigham and Womens Hospital (BWH). She participates in team-based chronic pain management at the BWH Pain Management Center and recently implemented a pharmacist-run chronic pain management clinic within the hospitals Phyllis Jen Center for Primary Care. She additionally works within a collaborative care model to improve the management of opioid abuse within primary care through a grant sponsored by Harvard Medical School. Dr. Matthews is a Certified Pain Educator and is a member of the Section Advisory Group member for Pain and Palliative Care for the American Society of Health-System Pharmacists. She has presented both locally and nationally on pain management-related topics and actively participates in clinical research pertaining the misuse and abuse of opioid analgesics in patients with chronic noncancer pain.
|
Mary Lynn McPherson,
PharmD, BCPS, Professor and Vice Chair,
University of Maryland School of Pharmacy
|
Mary Lynn McPherson, Pharm.D., BCPS,CPE, is Professor and Vice Chair in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore. She has maintained a practice in both hospice and palliative care, and ambulatory care her entire career. At present, Dr. McPherson is the Director of Pharmacotherapy Services at UniversityCare Heritage Crossing in Baltimore. Dr. McPherson teaches extensively in the Pharm.D. curriculum on pain management and end of life care, including didactic and experiential content. She also developed one of the first and few palliative care pharmacy residencies in the U.S.
Dr. McPherson serves on the Board of the Hospice Network of Maryland and is also President of the American Society of Pain Educators. McPherson is a Fellow in the American Society of Health-Systems Pharmacists, the American Pharmacists Association, and the American Society of Consultant Pharmacists. She has received many honors for her work, including the American Pharmacists Association Distinguished Achievement Award in Specialized Practice, the Maryland Pharmacists Association Innovative Practice Award, and the Maryland Society of Health-Systems Pharmacists W. Purdum Lifetime Achievement Award. She has written four books, and many book chapters and peer-reviewed articles on pain management, palliative care, and other topics.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Ernest Dole,
PharmD, BCPS, Clinical Pharmacist,
Pain Consultation & Treatment Clinic, University of New Mexico Hospitals
|
Dr. Dole is Clinical Staff Pharmacist III at University of New Mexico Hospitals (UNMH), Department of Clinical Pharmacy and Clinical Associate Professor at University of New Mexico Health Sciences College of Pharmacy. Dr. Dole manages ambulatory care patients with chronic noncancer pain. He received his B.S. in Pharmacy from Colorado, with honors, and his Doctor of Pharmacy degree from Tennessee. He completed a clinical pharmacy practice residency at the Memphis VAMC. Dr. Dole was the ninth Pharmacist Clinician in New Mexico in 1996, was recognized as an ASHP fellow in 1997, passed the Board of Pharmaceutical Specialties Pharmacotherapy exam in 1997, and Certified Diabetes Educator exam in 2000. Dr. Dole has twice been nominated for the NMSHP Pharmacist of the Year. He has been the Chair of American Society of Health-System Pharmacists Section of Home, Ambulatory and Chronic Care Practitioners and has served as a member on ASHP Councils and Task Forces. He has been president of the New Mexico Society of Health-System Pharmacists. Dr. Dole received the Volunteer Faculty of the Year Award and Preceptor of the Year Award from University of New Mexico Health Sciences College of Pharmacy in 2009. Current research is obtaining billing privileges for pharmacists, effect of high opiate doses on testosterone levels and the effect of opiates on sleep apnea.
|
Description
Overview of Effect of Comorbid Disorders on Opiate Response, Mary Lynn McPherson, PharmD, BCPS, FASHP
Overview of the Effect of PTSD on Chronic Pain, Ernest J. Dole, PharmD, BCPS, FASHP
Overview of the Impact That Sleep Apnea Can Have on Opiate Response, Christopher M. Herndon, PharmD, BCPS, FASHP
Overview of the Use of High Dose Opiate Therapy and Opiate Overdose, Michele L. Matthews, PharmD, CPE
- Describe common symptoms of PTSD in a patient with chronic pain and develop a medication regimen that reflects application of the best evidence ad current guidelines.
- Describe the risk of opiate overdose in patients receiving high dose opiates.
- Develop a medication regimen that reflects application of the best evidence and current guidelines in a patient with sleep apnea who is receiving opiates.
- Recognize the impact that comorbid conditions such as hypothyroidism and low vitamin D can have on the response to opiate therapy and be able to develop a medication regimen that reflects application of the best evidence and current guidelines.
